CTech 24/7
- Syte files for insolvency after burning through $70 million in funding
- Calibrate bigger: Rapidly adapting to a paradigm shift in tech investment
- Advanced companies have already restructured around AI, says Pentera’s CPO
- The rise of AI-driven phishing attacks: A growing threat and the power of smarter defenses
More stories in CTechPfizer
31 stories about Pfizer
CytoReason raises $80 million, including from NVIDIA and Pfizer, to scale its AI disease models
Technion and Pfizer sign agreement to boost drug development with AI
CytoReason raises $20 million from Pfizer for AI drug discovery and development platform
Israeli study reveals South African variant may evade Pfizer vaccine
Moderna CMO suggests Israel is on its radar for new vaccine production facility
Proof in the numbers: Israeli HMO reinforces Covid-19 vaccine efficacy findings by Pfizer
Survey finds majority of Israelis aren’t worried about sharing vaccine data with drug companies
Israel includes teens in vaccination drive, eyeing exams
Dissecting the data-sharing deal: Should Israelis be worried about Pfizer getting private info?
Human experimentation oversight committee wants to approve Israel-Pfizer data-sharing deal
How did an Israeli robotics company catch Elon Musk's attention and why is every criminal on the planet your next-door neighbor?
Responding to calls for transparency, Israel publishes contract of data-sharing vaccine deal with Pfizer
“We’re lucky that the mutations only affected the rate of infection, they could have created a far more violent virus”
Israel’s one of a kind healthcare system is a rare opportunity for Pfizer
Israel can use medical data to defeat the virus without violating people’s privacy
How is technology and data helping Israel become the first country to vanquish Covid-19?
These are the key ingredients of Israel's rapid Covid-19 vaccine rollout recipe
Pfizer, AstraZeneca, Merck, and Teva win tender for new Israeli Innovation Lab
Will the quickly developed vaccines deliver Covid-19 a knockout blow?
Survey: One-third of Israelis would prefer to take homegrown Covid-19 vaccine
10.12.20The results come a day after America’s Pfizer/BioNTech vaccine touches down for distribution
Load more
